Accession Number: | 0000899243-21-024530 |
Date: | 2021-06-15 |
Issuer: | AILERON THERAPEUTICS INC (ALRN) |
Original Submission Date: |
AMBROS REINHARD J.
C/O AILERON THERAPEUTICS, INC.
285 SUMMER STREET, SUITE 101
BOSTON, MA 02210
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 1.29 | 2021-06-15 | deemed execution date | A | 96,000 (a) | 2031-06-14 | common stock 96,000 | $1.29 | 96,000 | direct |
ID | footnote |
---|---|
f1 | this option was granted on june 15, 2021. the shares underlying the option are scheduled to vest in full on the earlier of (i) june 15, 2022 or (ii) the date of the issuer's 2022 annual meeting of stockholders. |